1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma (MUM) and reveals a novel prognostic biomarker signature for MUM. Our recent findings support ferroptosis as a potential clinical biomarker and therapeutic target for MUM.
nature.com/articles/s4142…
nature.com/articles/s4142…